InsiderSource
RXST

RxSight, Inc.

SEC CIK 1111485
$4.71 −40.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
46
Most recent
Advertisement

At a glance

Insiders at RXST have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Thunen Shelley B sold $1.5M of RXST, trimming their stake 82%.

Most active filer: Thunen Shelley B, with 27 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for RXST, newest first
View on SEC EDGAR ↗
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −4.1%

Thunen Shelley B sold $40.2K of RXST, trimming their stake 4%.

−$40.2K
800 sh @ $50
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −48%

Thunen Shelley B sold $445.2K of RXST, trimming their stake 48%.

−$445.2K
8,938 sh @ $50
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −6.8%

Thunen Shelley B sold $33.3K of RXST, trimming their stake 7%.

−$33.3K
662 sh @ $50
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −2.2%

Thunen Shelley B sold $10.1K of RXST, trimming their stake 2%.

−$10.1K
200 sh @ $50
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −6.1%

Thunen Shelley B sold $28K of RXST, trimming their stake 6%.

−$28K
543 sh @ $52
Advertisement
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Mar 5, 2024 ΔOwn −4.9%

Thunen Shelley B sold $64.1K of RXST, trimming their stake 5%.

−$64.1K
1,166 sh @ $55
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Mar 5, 2024 ΔOwn −28%

Thunen Shelley B sold $358.6K of RXST, trimming their stake 28%.

−$358.6K
6,361 sh @ $56
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Mar 5, 2024 ΔOwn −15%

Thunen Shelley B sold $141K of RXST, trimming their stake 15%.

−$141K
2,473 sh @ $57
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Feb 7, 2024 ΔOwn −54%

Thunen Shelley B sold $753.6K of RXST, trimming their stake 54%.

−$753.6K
15,875 sh @ $47
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Feb 7, 2024 ΔOwn −40%

Thunen Shelley B sold $429.1K of RXST, trimming their stake 40%.

−$429.1K
9,125 sh @ $47
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jan 29, 2024 ΔOwn −82%

Thunen Shelley B sold $1.5M of RXST, trimming their stake 82%.

−$1.5M
31,772 sh @ $47
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jan 3, 2024 ΔOwn −37%

Thunen Shelley B sold $175.2K of RXST, trimming their stake 37%.

−$175.2K
4,519 sh @ $39
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jan 3, 2024 ΔOwn −71%

Thunen Shelley B sold $217.2K of RXST, trimming their stake 71%.

−$217.2K
5,481 sh @ $40
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Dec 18, 2023 ΔOwn −90%

Thunen Shelley B sold $787K of RXST, trimming their stake 90%.

−$787K
20,000 sh @ $39
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Dec 18, 2023 ΔOwn −21%

Thunen Shelley B sold $393.1K of RXST, trimming their stake 21%.

−$393.1K
10,000 sh @ $39
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Dec 18, 2023 ΔOwn −26%

Thunen Shelley B sold $393.2K of RXST, trimming their stake 26%.

−$393.2K
10,000 sh @ $39
Advertisement

About RXST insider activity

This page tracks every recent Form 4 filed for RxSight, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is RXST insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for RxSight, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.